| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5815880 | Neuropharmacology | 2012 | 10 Pages |
Abstract
⺠Antipsychotic drugs (APD) have little effect on negative and cognitive symptoms in schizophrenia. ⺠There appear to be few major differences between first and second generation APDs. ⺠Novel APD strategies focus on serotonin, glutamate, acetylcholine and PDE10. ⺠In addition, novel cognitive enhancer (5-HT6, H3) are being evaluated. ⺠A major breakthrough in therapy has yet to be identified.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Bart A. Ellenbroek,